← Back to Clinical Trials
Recruiting NCT06782165

NCT06782165 Long-term Follow up of TMJ Surgery and Evaluation of the 6-month Control as a Prognostic Marker.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06782165
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Temporomandibular Disorders (TMD)
Study Type OBSERVATIONAL
Enrollment 91 participants
Start Date 2025-04-01
Primary Completion 2026-02

Trial Parameters

Condition Temporomandibular Disorders (TMD)
Sponsor Karolinska Institutet
Study Type OBSERVATIONAL
Phase N/A
Enrollment 91
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2026-02
Interventions
Arthroscopy & saline irrigation aloneDiscectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to evaluate the long-term outcome of surgical intervention (arthroscopy or discectomy) due to the diagnoses temporomandibular joint disc displacement with or without displacement. The main questions it aims to answer are: * Does the surgical outcome recorded at the earlier 6-month follow up persist at the long-term follow up approximately 10 years postoperatively? * How does the radiologically determined degree of joint degeneration change with time in patients that have had joint surgery? Researchers will compare the six-month surgical outcome to the ten-year outcome to see if temporomandibular joint surgery results are stable over time. Participants with an earlier performed joint surgery will: * Have a clinical examination approximately ten years postoperatively. * Have a temporomandibular joint x-ray scan performed (cone-beam computed tomography).

Eligibility Criteria

Inclusion Criteria: * Patients participating in the studies with ethical approval numbers EPN 2014/764-31/2 and 2014/622-31/1. * Initial diagnosis DDwR or DDwoR. Exclusion Criteria: * Patient unable to verify informed consent.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology